相关实验视频
Updated: Jan 17, 2026

07:33
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
35.8K
RIP1与VEGF-C/NF-κB通路相关,有助于结直肠癌的进展和淋巴重塑
1Department of General Surgery The Second People's Hospital of Futian District Shenzhen Shenzhen China.
FASEB bioAdvances
|September 25, 2025
概括
受体相互作用蛋白激酶1 (RIP1) 通过增加VEGF-C和激活NF-κB促进结直肠癌 (CRC) 的进展. 针对RIP1可能为CRC治疗提供一个新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 受体相互作用蛋白激酶1 (RIP1) 与炎症和细胞存活有关.
- RIP1在结直肠癌 (CRC) 中的作用及其对瘤淋巴变化的影响尚不清楚.
研究的目的:
- 研究RIP1在结直肠癌 (CRC) 进展中的作用.
- 确定RIP1,VEGF-C表达和CRC中的NF-κB通路之间的关联.
- 评估RIP1对淋巴重塑和瘤生长的影响.
主要方法:
- 定量实时PCR (qRT-PCR) 和西部涂抹来评估CRC组织中的RIP1和VEGF-C表达.
- 使用RIP1沉默和重新表达的CRC细胞系 (HT29,SW480) 的功能测试.
- 在体内外移植的小鼠模型来评估瘤生长和血管化.
主要成果:
- 在CRC组织中,RIP1表达升高,与VEGF-C.正相关.
- RIP1的淘汰减少了CRC细胞的增殖,迁移,VEGF-C水平和NF-κB活性.
- 缺乏RIP1会影响淋巴内皮细胞管的形成,并抑制瘤生长 in vivo.
结论:
- RIP1通过增加VEGF-C表达和NF-κB通路激活促进结直肠癌 (CRC) 的进展.
- RIP1有助于CRC生长和淋巴重塑.
- RIP1代表了结直肠癌干预的潜在治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.4K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K

